CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...
Phase 2
Denver, Colorado, United States and 22 other locations
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Aurora, Colorado, United States and 18 other locations
COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention...
Denver, Colorado, United States and 43 other locations
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Aurora, Colorado, United States and 9 other locations
A Randomized Control Trial (RCT) with 1:1 randomization of adults newly diagnosed with type 2 diabetes (T2D) to Routine Care (RC) and RC + G...
Aurora, Colorado, United States and 1 other location
This study plans to learn more about the effect of semaglutide once weekly on intestinal permeability in individuals with type 2 diabetes....
Phase 4
Aurora, Colorado, United States
The IMPACT study is a study to test a new experimental drug, IMCY-0098, for the treatment of type 1 diabetes (T1D).In most people with type ...
Phase 2
Aurora, Colorado, United States and 28 other locations
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question[s] it aims to answer...
Phase 2
Aurora, Colorado, United States and 5 other locations
INHALE-3 is a Phase 4, randomized controlled trial (RCT) that will randomly assign participants ≥18 years of age with type 1 diabetes (T1D) ...
Phase 4
Aurora, Colorado, United States and 18 other locations
study is to measure the safety and efficacy of insulin efsitora alfa (LY3209590) compared with insulin degludec in participants with type 1 diabetes...
Phase 3
Aurora, Colorado, United States and 76 other locations
Clinical trials
Research sites
Resources
Legal